Funding news
Math Biology logo

Revolutionizing Healthcare: Math Biology Secures $1.5 Million in Funding for Breakthrough Health Technology

Recently funded · $1.5MHealth Technology

Get the full Math Biology company profile

Access contacts, investors, buying signals & more

Open in Dashboard

We are thrilled to announce that Math Biology, an innovative start-up revolutionizing health technology, has successfully raised $1,500,000 in its latest funding round. This significant investment will be pivotal in advancing our mission to provide non-invasive health screening solutions for the Clinical and Wellness & Sport sectors. Our cutting-edge technology allows for a comprehensive examination of organs and cerebral districts, significantly enhancing the standard clinical tests. The funds will primarily be utilized to further develop our flagship product, the Deep Metabolism Assessment (DMA), which leverages a wealth of data—over 20,000 sets—to advance early disease diagnosis and personalized care interventions. By identifying patterns linked to altered metabolic reactions (dysmetabolism), our approach not only promises to predict illness but also supports timely treatments and continuous monitoring. Utilizing innovative biosensors akin to ECG technology, we capture subtle electrical signals across various body points, which are then analyzed through sophisticated artificial intelligence algorithms. This uniquely positions us to assess the health status of specific organs, the Central Nervous System (CNS), and glands with unprecedented accuracy. We are immensely grateful to our investors for their belief in our vision and are excited to embark on this new chapter, paving the way for accessible, non-invasive health technology that enhances quality of life. Stay updated on our journey by visiting us at www.MathBiology.tech.

Other recently funded companies

View all